← All Nanonews
LeishGen wins Best Oral Communication at ALIVE2 in Nice
Drug resistance in the parasite is a major obstacle to treating canine leishmaniosis in the Mediterranean, and the Leishmania infantum genome offers a way to study it.
Nano1Health attended ALIVE2, the Animal Leishmaniosis International Veterinary Event organised by LeishVet in Nice on 19 and 20 April 2024. The congress helped us build collaborations with veterinarians, researchers and industry.
Marina Carrasco presented LeishGenApp and LeishGenR™, developed over two years within a Neotec project supported by CDTI. Her talk on drug-resistance biomarkers using nanopore sequencing and structural-variant analysis won the Best Oral Communication award in research.
Questions about this news? Write to info@nano1health.com.